January 29, 2009
Strategic BioSciences Announces Major Formulation Breakthrough for Loratadine. (pdf file)
January 16, 2009
Fortune Apex Development LTD and SRxA Holdings LLC signed Binding Memorandum of Understanding. (pdf file)
March 20, 2008
A study presented at the AAAAI Annual Meeting, shows MucoAd™ delayed nasal clearance offering significant benefits to nasal spray users. (pdf file)
March 19, 2008
Clinical data shows MucoAd™ may offer significant benefits for patients suffering from dry eye syndrome and other eye conditions. (pdf file)
May 8, 2007
Strategic Pharmaceuticals Company, doing business as Strategic BioSciences, licenses the exclusive global rights to MucoAd™ (pdf file)